People · Operator

Fredrik Wiklund

Named in public records as an officer, director or promoter · active 2021–2024 · Pharma

1
Companies
2
Filings
$196.5M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Bright Peak Therapeutics, Inc.PharmaSeries D+$196.5M$1.0B2021
Operator network

Fredrik Wiklund at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Asish Xavier · 18 companies · 1 sharedAsish XavierJosh Resnick · 7 companies · 1 sharedJosh ResnickLaura Shawver · 6 companies · 1 sharedLaura ShawverAlexander Mayweg · 4 companies · 1 sharedAlexander MaywegChristine Siu · 2 companies · 1 sharedChristine SiuEMILY MINKOW · 2 companies · 1 sharedEMILY MINKOWJacob Chacko · 2 companies · 1 sharedJacob ChackoTom Woiwode · 2 companies · 1 sharedTom WoiwodeBertolt Kreft · 1 companies · 1 sharedBertolt KreftJon Wigginton · 1 companies · 1 sharedJon WiggintonLeena Gandhi · 1 companies · 1 sharedLeena GandhiMatthew Robbins · 1 companies · 1 sharedMatthew RobbinsMichael Rosenzweig · 1 companies · 1 sharedMichael RosenzweigVijaya Pattabiraman · 1 companies · 1 sharedVijaya Pattabiram…Bright Peak Therapeutics, Inc. · $196.5M raisedBright Peak Therapeut…Fredrik WiklundFW
Fredrik Wiklund Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Fredrik Wiklund on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Asish Xavier118
Josh Resnick17
Laura Shawver16
Alexander Mayweg14
Christine Siu12
Tom Woiwode12
EMILY MINKOW12
Jacob Chacko12
Vijaya Pattabiraman11
Jon Wigginton11
Bertolt Kreft11
Michael Rosenzweig11
Matthew Robbins11
Leena Gandhi11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.